Table 1.

Clinical trials using hESC-RPE and iPSC-derived cells

hESC-RPE cellular therapy		iPSC-derived cells in clinical trials
Condition	ClinicalTrials.gov Identifier number/ Phase/ Status	Condition	ClinicalTrials.gov Identifier number/ Source/ Status
Age Related Macular Degeneration, Stargardt's Disease, Exudative Age-related, Macular Degeneration	NCT02903576/ I/II/ study is currently recruiting participants	Leukemia, Lymphoma	NCT02564484/ blood/ study is currently recruiting participants
Dry Age Related Macular Degeneration	NCT01344993/ I/II/ study has been completed	Ataxia-Telangiectasia (A-T)	NCT02246491/ blood, skin/ study is currently recruiting participants
Stargardt's Macular Dystrophy	NCT01345006/ I/II/ study has been completed	Chronic Granulomatous Disease	NCT02926963/ hair, skin/ study is currently recruiting participants
Dry Age-related Macular Degeneration	NCT03046407/ early 1/ study is currently recruiting participants	Retinoblastoma	NCT02193724/ skin, blood/ study is currently recruiting participants
Stargardt's Macular Dystrophy	NCT01469832/ I/II/ study has been completed	Autism Spectrum Disorder	NCT02720939/ blood/ study is currently recruiting participants
Dry Macular Degeneration, Geographic Atrophy	NCT02590692/ I/II/ study is currently recruiting participants	Ectodermal Dysplasia	NCT02896387/ skin, cornea/ study is currently recruiting participants
Dry Age-related Macular Degeneration	NCT02755428/ early 1/ study is currently recruiting participants	Intellectual Deficiency, Asymptomatic Carrier of the Mutation of the Gene MYT1L, Healthy Volunteers
Macular Degeneration, Stargardt's Macular Dystrophy	NCT02749734/ I/ study is currently recruiting participants		NCT02980302/ skin/ study is currently recruiting participants
Age-related Macular Degeneration	NCT02286089/ I/II/ study is currently recruiting participants
Age-related Macular Degeneration	NCT03102138/ I/ study is currently recruiting participants